NCT02524002

Brief Summary

The goal of the study is to see if the addition of a carbohydrate- and protein-enhanced gel during labor speeds labor and reduces the rate of cesarean delivery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

August 15, 2014

Completed
12 months until next milestone

First Posted

Study publicly available on registry

August 14, 2015

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

June 12, 2018

Status Verified

June 1, 2018

Enrollment Period

2.9 years

First QC Date

August 15, 2014

Last Update Submit

June 8, 2018

Conditions

Keywords

Abnormal LaborProlonged InductionKetosisDiet

Outcome Measures

Primary Outcomes (1)

  • Time from admission to delivery

    Up to 3 days from time of admission

    Participants will be followed during labor until delivery, an expected range of 1-48 hours

Secondary Outcomes (6)

  • Duration of second stage of labor

    Participants will be followed during labor until delivery, an expected range of 1-48 hours

  • delivery in <24 hours

    Participants will be followed during labor until delivery, an expected range of 1-48 hours

  • cesarean delivery

    Participants will be followed during labor until delivery, an expected range of 1-48 hours

  • rate of composite adverse GI outcome (vomiting or diarrhea)

    Participants will be followed for the duration of hospital stay, an expected average of 5 days

  • patient satisfaction with diet

    Participants will be followed during labor until delivery, an expected range of 1-48 hours

  • +1 more secondary outcomes

Study Arms (2)

Usual Clear Diet

PLACEBO COMPARATOR

This intervention consists of soup broth, variety of juices (apple, cranberry, grape), ginger ale, water, and ice.

Dietary Supplement: Usual clear diet

Accel Gel

EXPERIMENTAL

This intervention is an enhanced clear liquid gel is Accel Gel, produced by PacificHealth Labs of Matawan, NJ. This gel has 4:1 carb to protein ratio formula, and ingredients that are not contraindicated in pregnancy (only the flavors with minimal caffeine are used). http://www.pacifichealthlabs.com/accel-gel-all-natural-rapid-energy-gel-product.html

Dietary Supplement: Accel Gel

Interventions

Accel GelDIETARY_SUPPLEMENT

Accel Gel by PacificHealth Labs in Matawan, NJ.

Accel Gel
Usual clear dietDIETARY_SUPPLEMENT

Usual clear liquids

Usual Clear Diet

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Nulliparity (first baby)
  • Admission with the intent to deliver vaginally
  • Gestational age \>36 weeks
  • Age ≥ 18

You may not qualify if:

  • Planned cesarean delivery
  • Renal Disease
  • Preeclampsia
  • Diabetes (Pre-gestational or Gestational)
  • Allergy to any component of sports drink
  • NPO diet by physician

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Temple University Hospital

Philadelphia, Pennsylvania, 19102, United States

Location

MeSH Terms

Conditions

DystociaKetosis

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesAcidosisAcid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Laura Goetzl, M.D.

    Temple University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 15, 2014

First Posted

August 14, 2015

Study Start

August 1, 2014

Primary Completion

July 1, 2017

Study Completion

July 1, 2017

Last Updated

June 12, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will share

Locations